Cuba and Kazakhstan will expand their cooperation in the fields of biotechnology and health, with the visit to the Eurasian country of an important delegation composed of representatives of the Cuban business group Biocubafarma and the Centre for Molecular Immunology.
The website of the Cuban Foreign Ministry informed that the visit is headed by Dr. Idania Caballeros Torres, director of the Biocubafarma Representation in Moscow and for the entire post-Soviet area, and its objective is to follow up and sustain negotiations with Kazakh counterparts on the introduction and use of Cuban medicines in that country, as well as to explore new possibilities and fields of cooperation between both nations in the biotechnological and health fields.
The Cuban representatives develop an intense program of visits to medical, scientific, academic, educational and governmental institutions, as well as holding a series of meetings and negotiations on various joint projects aimed at strengthening cooperation and a greater and broader approach to the advances of Cuban biotechnology.
In her statements upon arrival in this country, Caballeros Torres referred to the importance of this type of visits and negotiations for the development of exchange between the peoples and institutions of Cuba and Kazakhstan, since they allow to verify the potentialities for cooperation and to advance ongoing negotiations for the realization of important exchange projects between both countries.
At the same time, the Cuban ambassador, Emilio Pevida Pupo, stressed his satisfaction with the visit of Cuban directors, scientists and researchers, which will undoubtedly contribute to the strengthening of bilateral relations between both countries, particularly in the field of health, biotechnology and the pharmaceutical industry, as well as a greater dissemination of the important and innovative advances of the Caribbean nation in these fields in the vast territory of this enormous country and throughout Central Asia.
Biocubafarma is a business organization that produces medicines, equipment and high-tech services related to human health, has 62 production facilities, and among its results has 802 health records and exports to 48 countries.
The Center for Molecular Immunology is one of the main centers of this sector in Cuba, with more than 30 awards from the Cuban Academy of Sciences, was inaugurated on December 5, 1994 by the leader of the Revolution Fidel Castro Ruz.
Its CIMAvax-EGF vaccine is a world reference in its use for the treatment of very advanced stages of cancer with null surgical possibilities, and has other products online and registered, including CIMAher, for the treatment of tumors of the head, neck, esophagus and pancreas, and iorEPOCIM, 2000, 4000 and 10000, for the treatment of anemia in chronic renal failure, AIDS, and cancer patients under chemotherapy regimen.